{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:15:10Z","timestamp":1792080910334,"version":"4.4.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Over the past decade many previously poorly understood vascular malformation disorders have been linked to somatic activating mutations in PIK3CA, which regulates cell survival and growth via activation of the mTOR1-AKT pathway. The goal of this article is to describe and provide an update on the clinical features, complications, and management strategies for the PIK3CA-related overgrowth spectrum (PROS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>PROS encompasses a heterogenous group of disorders with complications related to the tissues harboring the mutation. Vascular malformation syndromes, such as Klippel\u2013Trenaunay syndrome and Congenital Lipomatous Overgrowth Vascular malformations Epidermal nevi and Skeletal abnormalities, have an increased risk of thromboembolic complications, which is accentuated postprocedurally. Asymmetric overgrowth, particularly of limbs, results in a high rate of orthopedic complications. Hypoglycemia screening in the neonatal period and ongoing monitoring for growth failure is recommended in megalencephaly capillary malformation due to its association with multiple endocrinopathies. Recently, sirolimus, an mTOR1 inhibitor, has shown promise in vascular anomalies and now PROS. PIK3CA direct inhibitor, Alpelisib (BYL719), was recently trialed with significant clinical benefit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>As the pathogenesis of these conditions is better elucidated and targeted treatments are developed, recognizing the clinical features, comorbidities, and evolving therapeutic landscape across the PROS spectrum becomes more crucial for optimization of care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000923","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T13:00:40Z","timestamp":1594126840000},"page":"539-546","source":"Crossref","is-referenced-by-count":50,"title":["PIK3CA vascular overgrowth syndromes: an update"],"prefix":"10.1097","volume":"32","author":[{"given":"Meagan","family":"Hughes","sequence":"first","affiliation":[{"name":"Department of Dermatology, USC Keck School of Medicine and Children's Hospital Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Hao","sequence":"additional","affiliation":[{"name":"USC Keck School of Medicine, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minnelly","family":"Luu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, USC Keck School of Medicine and Children's Hospital Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","article-title":"Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum","volume":"164A","author":"Keppler-Noreuil","year":"2014","journal-title":"Am J Med Genet A"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.36836","article-title":"PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation","volume":"167A","author":"Keppler-Noreuil","year":"2015","journal-title":"Am J Med Genet A"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"e87623","DOI":"10.1172\/jci.insight.87623","article-title":"PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution","volume":"1","author":"Mirzaa","year":"2016","journal-title":"JCI Insight"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molmed.2018.08.003","article-title":"Cancer-associated PIK3CA mutations in overgrowth disorders","volume":"24","author":"Madsen","year":"2018","journal-title":"Trends Mol Med"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jpeds.2015.07.049","article-title":"Clinical and genetic aspects of the segmental overgrowth spectrum due to somatic mutations in PIK3CA","volume":"167","author":"Kang","year":"2015","journal-title":"J Pediatr"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1089\/wound.2018.0835","article-title":"Wound-healing problems associated with combined vascular malformations in Klippel\u2013Trenaunay Syndrome","volume":"8","author":"Ishikawa","year":"2019","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaad.2003.12.017","article-title":"Klippel\u2013Tr\u00e9naunay syndrome: the importance of \u2018geographic stains\u2019 in identifying lymphatic disease and risk of complications","volume":"51","author":"Maari","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"100634","DOI":"10.1016\/j.tvir.2019.100634","article-title":"Klippel\u2013Trenaunay syndrome","volume":"22","author":"John","year":"2019","journal-title":"Tech Vasc Interv Radiol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaad.2018.05.1245","article-title":"Pain, psychiatric comorbidities, and psychosocial stressors associated with Klippel\u2013Trenaunay syndrome","volume":"79","author":"Harvey","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jvsv.2018.01.015","article-title":"Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal\/skeletal abnormalities and Klippel\u2013Tr\u00e9naunay syndrome","volume":"6","author":"Reis","year":"2018","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ajmg.c.31735","article-title":"Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome","volume":"181","author":"Keppler-Noreuil","year":"2019","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R12-20230918","first-page":"48","article-title":"Klippel\u2013Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension","volume":"76","author":"Seferian","year":"2019","journal-title":"Respir Med Res"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jvscit.2018.12.016","article-title":"Implementation of new endovenous treatments in therapy for lateral embryonic veins","volume":"5","author":"Huegel","year":"2019","journal-title":"J Vasc Surg Cases Innov Tech"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/ped.13804","article-title":"Laser ablation of embryonic veins in children","volume":"61","author":"Bittles","year":"2019","journal-title":"Pediatr Int"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1302\/1863-2548.13.190065","article-title":"Orthopaedic diagnoses in patients with Klippel\u2013Trenaunay syndrome","volume":"13","author":"Schoch","year":"2019","journal-title":"J Child Orthop"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.arth.2018.12.028","article-title":"Total knee arthroplasty is safe and successful in patients with Klippel\u2013Tr\u00e9naunay syndrome","volume":"34","author":"Labott","year":"2019","journal-title":"J Arthroplasty"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cge.12832","article-title":"CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS)","volume":"91","author":"Martinez-Lopez","year":"2017","journal-title":"Clin Genet"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.jhsa.2013.08.120","article-title":"CLOVES syndrome","volume":"38","author":"Bloom","year":"2013","journal-title":"J Hand Surg Am"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1148\/rg.2019180136","article-title":"Congenital limb overgrowth syndromes associated with vascular anomalies","volume":"39","author":"Bertino","year":"2019","journal-title":"Radiographics"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41439-019-0063-9","article-title":"A girl with CLOVES syndrome with a recurrent","volume":"6","author":"Hanafusa","year":"2019","journal-title":"Hum Genome Var"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/GIM.0b013e31819436cf","article-title":"Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia","volume":"11","author":"Clericuzio","year":"2009","journal-title":"Genet Med"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"e26684","DOI":"10.1002\/pbc.26684","article-title":"Sonographic screening for Wilms tumor in children with CLOVES syndrome","volume":"64","author":"Peterman","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/lrb.2018.0049","article-title":"Cancer risk in Klippel\u2013Trenaunay syndrome","volume":"17","author":"Blatt","year":"2019","journal-title":"Lymphat Res Biol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1542\/peds.113.4.e326","article-title":"Wilms tumor screening is unnecessary in Klippel\u2013Trenaunay syndrome","volume":"113","author":"Greene","year":"2004","journal-title":"Pediatrics"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/archdermatol.2008.545","article-title":"The misnomer \u2018macrocephaly-cutis marmorata telangiectatica congenita syndrome\u2019: report of 12 new cases and support for revising the name to macrocephaly-capillary malformations","volume":"145","author":"Wright","year":"2009","journal-title":"Arch Dermatol"},{"issue":"(Pt 6)","key":"R26-20230918","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/brain\/awv045","article-title":"PI3K\/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia","volume":"138","author":"Jansen","year":"2015","journal-title":"Brain"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajmg.c.31361","article-title":"Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP","volume":"163C","author":"Mirzaa","year":"2013","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/cge.13145","article-title":"Hypoglycaemia represents a clinically significant manifestation of PIK3CA- and CCND2-associated segmental overgrowth","volume":"93","author":"McDermott","year":"2018","journal-title":"Clin Genet"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ajmg.a.61403","article-title":"Growth hormone deficiency in megalencephaly-capillary malformation syndrome: an association with activating mutations in PIK3CA","volume":"182","author":"Davis","year":"2020","journal-title":"Am J Med Genet A"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1084\/jem.20181353","article-title":"Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly","volume":"216","author":"Rodriguez-Laguna","year":"2019","journal-title":"J Exp Med"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.sempedsurg.2014.07.006","article-title":"Complex lymphatic anomalies","volume":"23","author":"Trenor","year":"2014","journal-title":"Semin Pediatr Surg"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaad.2013.05.030","article-title":"Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy","volume":"69","author":"Lee","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jaad.2017.06.014","article-title":"Wilms tumor screening in diffuse capillary malformation with overgrowth and macrocephaly-capillary malformation: a retrospective study","volume":"77","author":"Peterman","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ng.2332","article-title":"Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA","volume":"44","author":"Lindhurst","year":"2012","journal-title":"Nat Genet"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-8628(19981002)79:4<311::AID-AJMG14>3.0.CO;2-U","article-title":"Clinical differentiation between Proteus syndrome and hemihyperplasia: description of a distinct form of hemihyperplasia","volume":"79","author":"Biesecker","year":"1998","journal-title":"Am J Med Genet"},{"key":"R36-20230918","first-page":"251","article-title":"Hemihyperplasia-multiple lipomatosis syndrome associated with hydrocephalus","volume":"25","author":"Erpolat","year":"2014","journal-title":"Genet Couns"},{"key":"R37-20230918","first-page":"714","article-title":"Hemihyperplasia-multiple lipomatosis syndrome (HHML): a challenge in spinal care","volume":"74","author":"Schulte","year":"2008","journal-title":"Acta Orthop Belg"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"12e","DOI":"10.1097\/01.prs.0000436822.26709.7c","article-title":"PIK3CA activating mutations in facial infiltrating lipomatosis","volume":"133","author":"Maclellan","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s003300000427","article-title":"Congenital infiltrating lipomatosis of the face with cerebral abnormalities","volume":"10","author":"Unal","year":"2000","journal-title":"Eur Radiol"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3171\/2013.12.JNS13174","article-title":"Segmental thoracic lipomatosis of nerve with nerve territory overgrowth","volume":"120","author":"Mahan","year":"2014","journal-title":"J Neurosurg"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3171\/2016.2.JNS151051","article-title":"A new pattern of lipomatosis of nerve: case report","volume":"126","author":"Prasad","year":"2017","journal-title":"J Neurosurg"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/gim.2017.200","article-title":"CLAPO syndrome: identification of somatic activating PIK3CA mutations and delineation of the natural history and phenotype","volume":"20","author":"Rodriguez-Laguna","year":"2018","journal-title":"Genet Med"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12881-018-0672-z","article-title":"Upper limb muscle overgrowth with hypoplasia of the index finger: a new over-growth syndrome caused by the somatic PIK3CA mutation c.3140A>G","volume":"19","author":"Al-Qattan","year":"2018","journal-title":"BMC Med Genet"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1002\/mgg3.536","article-title":"Molecular diagnosis of somatic overgrowth conditions: a single-center experience","volume":"7","author":"Lalonde","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/gcc.22739","article-title":"Comprehensive molecular and clinicopathological analysis of vascular malformations: a study of 319 cases","volume":"58","author":"Ten Broek","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng.2331","article-title":"De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes","volume":"44","author":"Rivi\u00e8re","year":"2012","journal-title":"Nat Genet"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/cge.13195","article-title":"Causal somatic mutations in urine DNA from persons with the CLOVES subgroup of the PIK3CA-related overgrowth spectrum","volume":"93","author":"Michel","year":"2018","journal-title":"Clin Genet"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/ajmg.a.36672","article-title":"Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes","volume":"164A","author":"Emrick","year":"2014","journal-title":"Am J Med Genet A"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jamadermatol.2016.1008","article-title":"Life-threatening cutaneous bleeding in childhood Klippel\u2013Trenaunay syndrome treated with oral sirolimus","volume":"152","author":"Bessis","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R51-20230918","doi-asserted-by":"crossref","first-page":"e27614","DOI":"10.1002\/pbc.27614","article-title":"Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham\u2013Stout disease","volume":"66","author":"Ricci","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"e12991","DOI":"10.1111\/dth.12991","article-title":"CLAPO syndrome: effective response to treatment with oral rapamycin","volume":"32","author":"Gonz\u00e1lez-Hermosa","year":"2019","journal-title":"Dermatol Ther"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","article-title":"Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum","volume":"21","author":"Parker","year":"2019","journal-title":"Genet Med"},{"key":"R54-20230918","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","article-title":"Targeted therapy in patients with PIK3CA-related overgrowth syndrome","volume":"558","author":"Venot","year":"2018","journal-title":"Nature"},{"key":"R55-20230918","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jpag.2019.07.003","article-title":"Alpelisib treatment for genital vascular malformation in a patient with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal\/skeletal anomalies and\/or scoliosis (CLOVES) syndrome","volume":"32","author":"L\u00f3pez","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:27:11Z","timestamp":1695004031000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000923","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}